Geode Capital Management, LLC Kinnate Biopharma Inc. Transaction History

Geode Capital Management, LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$2.24 - $2.66 $30,011 - $35,638	13,398 Added 5.81%	244,151 $649,000
Q4 2023 Feb 13, 2024	BUY	$1.07 - $2.5 $9,885 - $23,097	9,239 Added 4.17%	230,753 $546,000
Q3 2023 Nov 13, 2023	BUY	$1.38 - $3.31 $51,157 - $122,705	37,071 Added 20.1%	221,514 $310,000
Q2 2023 Aug 11, 2023	SELL	$2.33 - $6.84 $608,004 - $1.78 Million	-260,946 Reduced 58.59%	184,443 $558,000
Q1 2023 May 15, 2023	BUY	$3.46 - $7.98 $47,661 - $109,924	13,775 Added 3.19%	445,389 $2.78 Million
Q4 2022 Feb 13, 2023	BUY	$5.26 - $12.19 $57,360 - $132,931	10,905 Added 2.59%	431,614 $2.63 Million
Q3 2022 Nov 14, 2022	BUY	$9.86 - $15.76 $100,818 - $161,146	10,225 Added 2.49%	420,709 $5.03 Million
Q2 2022 Aug 12, 2022	BUY	$7.43 - $13.0 $337,180 - $589,953	45,381 Added 12.43%	410,484 $5.18 Million
Q1 2022 May 13, 2022	BUY	$7.73 - $17.99 $11,370 - $26,463	1,471 Added 0.4%	365,103 $4.11 Million
Q4 2021 Feb 11, 2022	BUY	$16.5 - $25.48 $435,765 - $672,926	26,410 Added 7.83%	363,632 $6.44 Million
Q3 2021 Nov 12, 2021	BUY	$17.81 - $24.87 $1.78 Million - $2.49 Million	99,973 Added 42.14%	337,222 $7.76 Million
Q2 2021 Aug 13, 2021	SELL	$22.19 - $31.55 $29,557 - $42,024	-1,332 Reduced 0.56%	237,249 $5.52 Million
Q1 2021 May 12, 2021	BUY	$26.99 - $40.0 $5.64 Million - $8.36 Million	209,101 Added 709.3%	238,581 $7.43 Million
Q4 2020 Feb 12, 2021	BUY	$36.35 - $45.25 $1.07 Million - $1.33 Million	29,480 New	29,480 $1.17 Million

292K

Ticker KNTE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,145,600
Description
Kinnate Biopharma Inc., a biopharmaceutical company, focuses on the discovery and development of small molecule kinase inhibitors to treat genomically defined cancers in the United States. The company develops KIN-2787, a rapidly accelerated fibrosarcoma inhibitor for the treatment of patients with lung cancer, melanoma, and other solid tumors; ...

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Geode Capital Management, LLC with notifications on news.